» Articles » PMID: 31572364

Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells

Overview
Journal Front Immunol
Date 2019 Oct 2
PMID 31572364
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Antibody secreting cells (ASCs) are terminally differentiated cells of the humoral immune response and must adapt morphologically, transcriptionally, and metabolically to maintain high-rates of antibody (Ab) secretion. ASCs differentiate from activated B cells in lymph nodes and transiently circulate in the blood. Most of the circulating ASCs undergo apoptosis, but a small fraction of early ASCs migrate to the bone marrow (BM) and eventually mature into long-lived plasma cells (LLPCs). LLPC survival is controlled both intrinsically and extrinsically. Their differentiation and maintenance programs are governed by many intrinsic mechanisms involving anti-apoptosis, autophagy, and metabolism. The extrinsic factors involved in LLPC generation include BM stromal cells, cytokines, and chemokines, such as APRIL, IL-6, and CXCL12. In humans, the BM CD19CD38CD138 ASC subset is the main repository of LLPCs, and our recent development of an BM mimic provides essential tools to study environmental cues that support LLPC survival and the critical molecular mechanisms of maturation from early minted blood ASCs to LLPCs. In this review, we summarize the evidence of LLPC generation and maintenance and provide novel paradigms of LLPC maturation.

Citing Articles

Successful sequential therapy with rituximab and telitacicept in refractory Anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature review.

Zhang J, Hu M, Wang C, Guo S Front Immunol. 2025; 16:1509143.

PMID: 39981240 PMC: 11839722. DOI: 10.3389/fimmu.2025.1509143.


In vivo tracking of ex-vivo-generated Zr-oxine-labeled plasma cells by PET in a non-human primate model.

Young D, Edwards A, Quiroz Caceda K, Liberzon E, Barrientos J, Hong S Mol Ther. 2025; 33(2):580-594.

PMID: 39741408 PMC: 11852699. DOI: 10.1016/j.ymthe.2024.12.042.


SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination.

Nguyen D, Hentenaar I, Morrison-Porter A, Solano D, Haddad N, Castrillon C Nat Med. 2024; 31(1):235-244.

PMID: 39333316 PMC: 11750719. DOI: 10.1038/s41591-024-03278-y.


Increased autoreactivity and maturity of EBI2+ antibody-secreting cells from nasal polyps.

Bai J, Kato A, Hulse K, Wechsler J, Gujar V, Poposki J JCI Insight. 2024; 9(17).

PMID: 39253973 PMC: 11385095. DOI: 10.1172/jci.insight.177729.


The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination.

Seong H, Yoon J, Nham E, Choi Y, Noh J, Cheong H J Transl Med. 2024; 22(1):827.

PMID: 39242525 PMC: 11380214. DOI: 10.1186/s12967-024-05637-2.


References
1.
Cravedi P, Lessman D, Heeger P . Eosinophils are not required for the induction and maintenance of an alloantibody response. Am J Transplant. 2013; 13(10):2696-702. PMC: 3805706. DOI: 10.1111/ajt.12404. View

2.
Fan X, Steitz J . Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 1998; 17(12):3448-60. PMC: 1170681. DOI: 10.1093/emboj/17.12.3448. View

3.
Shi W, Liao Y, Willis S, Taubenheim N, Inouye M, Tarlinton D . Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells. Nat Immunol. 2015; 16(6):663-73. DOI: 10.1038/ni.3154. View

4.
Herrera D, Rojas O, Duarte-Rey C, Mantilla R, Angel J, Franco M . Simultaneous assessment of rotavirus-specific memory B cells and serological memory after B cell depletion therapy with rituximab. PLoS One. 2014; 9(5):e97087. PMC: 4018270. DOI: 10.1371/journal.pone.0097087. View

5.
Manz R, Thiel A, Radbruch A . Lifetime of plasma cells in the bone marrow. Nature. 1997; 388(6638):133-4. DOI: 10.1038/40540. View